DCF — TEXAS HEALTH HEART & VASCULAR HOSP
Enterprise Value: $-55.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-55.9M
Enterprise Value
$-18.1M
PV of Cash Flows
$-37.7M
PV of Terminal Value
$-60.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $49.0M | $-3.2M | -7.0% | $-5.3M | $-4.8M |
| Year 2 | $50.5M | $-2.8M | -6.0% | $-5.0M | $-4.1M |
| Year 3 | $52.0M | $-2.4M | -5.0% | $-4.6M | $-3.4M |
| Year 4 | $53.6M | $-2.2M | -4.0% | $-4.4M | $-3.0M |
| Year 5 | $55.2M | $-2.1M | -4.0% | $-4.4M | $-2.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-55.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$47.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07072342074534375
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5